Riskpilot← Back to searchSign inGet full accessVironova Bioanalytics AB
ABBankruptOrg 5568002959Technical testing and analysis · NACE 7120Est. 20100 employees
Revenue 2021
SEK 22,8M
+1577% vs 2020
EBITDA margin
-4.8%
+78% vs 2020
Equity ratio
0.3%
Financial strength
Net profit 2021
SEK -3,6M
+33% vs 2020
| Revenue | SEK 22,8M | +1577% |
| EBITDA | SEK -1,1M | +78% |
| Net profit | SEK -3,6M | +33% |
| Total assets | SEK 31,5M | +1071% |
| Equity | SEK 100K | +0% |
| Employees | 0 | — |
Legal name
Vironova Bioanalytics AB
Org number
5568002959
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
4 februari 2010
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Uppgift om firmateckning saknas Registrerad styrelse saknas.
Company purpose
Bolaget har som föremål för sin verksamhet att bedriva kontrakts- och annan forskning inriktad mot det virala området och även tillhandahålla laboratorie- forskning- och kliniska tjänster inom området, samt att bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1 759 | 1 354 | 2 613 | 1 360 | 22 812 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 382 | −6 451 | −6 047 | −4 907 | −1 095 |
| Depreciation & amort. | −77 | −169 | −400 | −487 | −2 532 |
| EBIT | −4 459 | −6 620 | −6 447 | −5 394 | −3 627 |
| Net financials | — | −1 | −1 | −1 | −6 |
| Profit before tax | −4 459 | −6 621 | −6 448 | −5 395 | −3 634 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 459 | −6 621 | −6 448 | −5 395 | −3 634 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 2 583 | 3 518 | 4 952 | 2 692 | 31 524 |
| Equity | 984 | 363 | 100 | 100 | 100 |
| Long-term debt | 0 | 1 886 | 1 886 | 1 656 | 1 656 |
| Short-term debt | 1 599 | 1 269 | 2 966 | 936 | 29 768 |
| Total debt | 1 599 | 3 155 | 4 852 | 2 592 | 31 424 |
EBITDA margin
-4.8%
This company
15.8%
Market median
-130% vs market
20172021
Equity ratio
0.3%
This company
38.2%
Market median
-99% vs market
20172021
Return on equity
-3634.0%
This company
18.4%
Market median
-19850% vs market
20172021
Net profit margin
-15.9%
This company
8.1%
Market median
-296% vs market
20172021
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20172021
Debt / equity
314.24×
This company
0.62×
Market median
-50584% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
LJ Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
MH Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2023 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
M Homman AB
Vironova Bioanalytics AB Board members of Vironova Bioanalytics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Tilander | Chief Auditor | 0 companies |
| Louise Josefina Nilsson | Chief Executive Officer | 0 companies |
| Mohamed Homman Loudiye | Chief Executive Officer | 0 companies |
| Mats Mikael Henriksson | Deputy Board Member | 0 companies |
| Maria Homman Loudiye | Deputy Board Member | 0 companies |